CVS Health Corporation (CVS) : Analyst Rating Update

CVS Health Corporation (CVS) : 15 brokerage houses believe that CVS Health Corporation (CVS) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on CVS Health Corporation (CVS). Zacks Investment Research suggests a Sell with a rank of 4.The median of all the 21 Wall Street Analysts endorse the stock as a Strong Buy with a rating of 1.48.

CVS Health Corporation (CVS) : The highest level CVS Health Corporation (CVS) is projected to reach is $123 for the short term and the lowest estimate is at $90. The consolidated price target from 22 rating analysts who initiate coverage on the stock is $111.61 and the possibility the share price can swing is $8.26.

CVS Health Corporation (NYSE:CVS): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $94.85 and $94.72 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $96.14. The buying momentum continued till the end and the stock did not give up its gains. It closed at $96.06, notching a gain of 1.14% for the day. The total traded volume was 5,637,513 . The stock had closed at $94.98 on the previous day.

Also, Morgan Stanley downgrades its rating on CVS Health Corporation (NYSE:CVS). The global brokerage major lowers the current price target from $111 per share to $104 per share. Analysts at the Morgan Stanley have a current rating of Equal-weight on the shares. The rating by the firm was issued on June 20, 2016. The company shares have dropped -8.84% from its 1 Year high price. On Jul 29, 2015, the shares registered one year high at $113.65 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $96.32 and the 200 Day Moving Average price is recorded at $98.41.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.